Pharmadent, LLC
Novel US Patent Topical Anesthetic for multiple medical fields including dentistry, oncology, dermatology, OTC, sports medicine
- Stage Full Product Ready
- Industry Healthcare Services
- Location Bethalto, IL, USA
- Currency USD
- Founded January 2012
- Employees 2
- Incorporation Type LLC
Company Summary
Company recently formed to hold the US patent ( 8,263,047) for exclusive licensure to a reputable company willing to acquire the pharmaceutical compound for marketing in the US. The company holds additional patents pending worldwide with additional filings expected in the future.
Team
-
Dr. Alan J Wickenhauserco-founder
practicing general dentist over 14 years, holder of US patent, opinion leader panel for Coltene Whaledent, lecturer, writer for national dental journal.
-
Stephen E Peipert, RpHco-founder
compound pharmacist over 30 years, holder of US patent, advisory panel for Southern Illinois University School of Pharmacy
-
Dr. Robert LakeRegulatory Director
recently retired, previous employment as the regulatory director for St. Judes Childrens Research Hospital; Memphis,TN.
-
Dr. Kevin RowlandChief Researcher (clinical and preclinical)
Professor of Physiology at Southern Illinois University School of Dental Medicine; Alton, IL. Extensive research in the subject of pain, nerve receptors. Published articles for patented topical.
Advisors
-
Grace Fishel, patent attorneyLawyerUnconfirmedCharles Tzinburg, CPAAccountantUnconfirmed
Previous Investors
-
no previous investorsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.